1. Home
  2. AROW vs ESPR Comparison

AROW vs ESPR Comparison

Compare AROW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • ESPR
  • Stock Information
  • Founded
  • AROW 1851
  • ESPR 2008
  • Country
  • AROW United States
  • ESPR United States
  • Employees
  • AROW N/A
  • ESPR N/A
  • Industry
  • AROW Major Banks
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • ESPR Health Care
  • Exchange
  • AROW Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • AROW 463.7M
  • ESPR 410.2M
  • IPO Year
  • AROW N/A
  • ESPR 2013
  • Fundamental
  • Price
  • AROW $26.40
  • ESPR $1.82
  • Analyst Decision
  • AROW Hold
  • ESPR Buy
  • Analyst Count
  • AROW 1
  • ESPR 6
  • Target Price
  • AROW $30.00
  • ESPR $7.25
  • AVG Volume (30 Days)
  • AROW 37.4K
  • ESPR 3.4M
  • Earning Date
  • AROW 01-30-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • AROW 4.27%
  • ESPR N/A
  • EPS Growth
  • AROW 0.27
  • ESPR N/A
  • EPS
  • AROW 1.77
  • ESPR N/A
  • Revenue
  • AROW $134,626,000.00
  • ESPR $295,451,000.00
  • Revenue This Year
  • AROW N/A
  • ESPR $186.86
  • Revenue Next Year
  • AROW $7.29
  • ESPR $9.41
  • P/E Ratio
  • AROW $14.81
  • ESPR N/A
  • Revenue Growth
  • AROW 3.11
  • ESPR 187.12
  • 52 Week Low
  • AROW $21.50
  • ESPR $1.58
  • 52 Week High
  • AROW $34.63
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • AROW 47.64
  • ESPR 38.40
  • Support Level
  • AROW $26.45
  • ESPR $1.82
  • Resistance Level
  • AROW $27.75
  • ESPR $1.91
  • Average True Range (ATR)
  • AROW 0.72
  • ESPR 0.09
  • MACD
  • AROW 0.08
  • ESPR 0.02
  • Stochastic Oscillator
  • AROW 65.79
  • ESPR 47.83

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. The company provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: